Drug Interactions Between Peficitinib, an Orally Administered, Once-Daily Janus Kinase Inhibitor, and Rosuvastatin in Healthy Subjects.

about

The role of the JAK/STAT signal pathway in rheumatoid arthritis.

P2860

Q55487787-46C7EEC3-7C17-48E8-B104-A44A4C4E8ADB

P2860

Drug Interactions Between Peficitinib, an Orally Administered, Once-Daily Janus Kinase Inhibitor, and Rosuvastatin in Healthy Subjects.

Item

http://www.wikidata.org/entity/Q46088850

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Drug Interactions Between Pefi ...... uvastatin in Healthy Subjects.

@en

Drug Interactions Between Pefi ...... uvastatin in Healthy Subjects.

@nl

type

Item

label

Drug Interactions Between Pefi ...... uvastatin in Healthy Subjects.

@en

Drug Interactions Between Pefi ...... uvastatin in Healthy Subjects.

@nl

prefLabel

Drug Interactions Between Pefi ...... uvastatin in Healthy Subjects.

@en

Drug Interactions Between Pefi ...... uvastatin in Healthy Subjects.

@nl

P1476

Drug Interactions Between Pefi ...... uvastatin in Healthy Subjects.

@en

P2093

Barbara Parker

http://www.w3.org/2001/XMLSchema#string

David Han

http://www.w3.org/2001/XMLSchema#string

James Keirns

http://www.w3.org/2001/XMLSchema#string

Jay P Garg

http://www.w3.org/2001/XMLSchema#string

Ogert Fisniku

http://www.w3.org/2001/XMLSchema#string

Tetsuya Nishimura

http://www.w3.org/2001/XMLSchema#string

Tomasz Wojtkowski

http://www.w3.org/2001/XMLSchema#string

Tong Zhu

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy and safety of the oral Janus kinase inhibitor peficitinib (ASP015K) monotherapy in patients with moderate to severe rheumatoid arthritis in Japan: a 12-week, randomised, double-blind, placebo-controlled phase IIb study

Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial).

Rosuvastatin pharmacokinetics in heart transplant recipients administered an antirejection regimen including cyclosporine.

Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial.

Rosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environment.

Pitavastatin is a more sensitive and selective organic anion-transporting polypeptide 1B clinical probe than rosuvastatin.

Organic anion transporting polypeptide 1B1: a genetically polymorphic transporter of major importance for hepatic drug uptake.

Eltrombopag increases plasma rosuvastatin exposure in healthy volunteers.

Role of the liver-specific transporters OATP1B1 and OATP1B3 in governing drug elimination.

The Use of Transporter Probe Drug Cocktails for the Assessment of Transporter-Based Drug-Drug Interactions in a Clinical Setting-Proposal of a Four Component Transporter Cocktail.

P2888

s40262-016-0474-4

P304

747-757

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40262-016-0474-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27878567

http://www.w3.org/2001/XMLSchema#string

Drug Interactions Between Peficitinib, an Orally Administered, Once-Daily Janus Kinase Inhibitor, and Rosuvastatin in Healthy Subjects.

about

P2860

P2860

Drug Interactions Between Peficitinib, an Orally Administered, Once-Daily Janus Kinase Inhibitor, and Rosuvastatin in Healthy Subjects.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698